Biologics CDMO Avid Bioservices announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act with respect to its pending $1.1 billion acquisition by GHO Capital Partners and Ampersand Capital Partners. GHO Capital Partners LLP, Ampersand Capital Partners #AvidBioservices #GHOCapitalPartners #AmpersandCapitalPartners #biologics #CDMO #pharmanews #pharmamanufacturing https://lnkd.in/gauGgf5d
Pharma Manufacturing’s Post
More Relevant Posts
-
Understanding the cost to manufacture a biologic requires gathering together a wide range of factors. It is a non-trivial exercise. Use EstiDATA biologics module from Rondaxe to make the task more straightforward and finally get a grip on the cost drivers. solutions@rondaxepharma.com #biologics #costofgoods #manufacturing
To view or add a comment, sign in
-
Find your cost drivers easy with EstiDATA. Schedule a demo anytime and see how to determine your CoGs easy and accurately. Solutions@rondaxepharma.com #biologics #costdrivers
Understanding the cost to manufacture a biologic requires gathering together a wide range of factors. It is a non-trivial exercise. Use EstiDATA biologics module from Rondaxe to make the task more straightforward and finally get a grip on the cost drivers. solutions@rondaxepharma.com #biologics #costofgoods #manufacturing
To view or add a comment, sign in
-
Rapidly reaching first-in-human studies can be challenging. Partnering with an experienced CDMO who supports clinical and commercial programs, leverages process and tech transfer expertise, and offers growing capacity for fed-batch programs at any stage of development, can help ease the path forward. And we don’t stop there. Learn how we can help support your next biologics program: https://hubs.ly/Q02-dCt40 #biologics #biologicsdevelopment
To view or add a comment, sign in
-
The cost to manufacture biologics is usually the sum of dozens of factors, but if one can bring them all together to review in a consistent format, often important opportunities for improvement become apparent. Use EstiDATA for biologics from Rondaxe to help sort through the haystack to find the factors that matter. solutions@rondaxepharma.com #biologics #costofgoods #manufacturing
To view or add a comment, sign in
-
Registering biologics in the RoW region is complex owing to multiple subcategories. Freyr's biologics registration services help understand the Regulatory framework for each subcategory and hasten market entry. Click here to know more. https://lnkd.in/gxw55hQZ #Biologics #RegistrationServices #RegulatoryAffairs #RoW #FreyrSolutions
To view or add a comment, sign in
-
Rapidly reaching first-in-human studies can be challenging. Partnering with an experienced CDMO who supports clinical and commercial programs, leverages process and tech transfer expertise, and offers growing capacity for fed-batch programs at any stage of development, can help ease the path forward. And we don’t stop there. Learn how we can help support your next biologics program: https://hubs.ly/Q02MM2ch0 #biologics #biologicsdevelopment
To view or add a comment, sign in
-
Learn how Custom Biologics designs and establishes methods suitable for comparability studies that allow for future use in validated #GMP lot release and stability testing. Afterwards, stop by Sartorius booth to learn more about Octet®️ BLI and download our new CQA eBook at the Bioprocessing Virtual Event Series: https://ow.ly/38wH50QXBsM #OctetBLI Labroots #LRBioprocessing #Bioprocessing #GMP #GXP #antibody #biologics #Biopharma #LotRelease #MonoclonalAntibody #WomenInScience
To view or add a comment, sign in
-
We understand what propels you – efficiency, quality, and flexibility. With accelerated path to clinic, simplified tech transfer, and innovative expressions and manufacturing platforms, we can propel your biologics program to its next milestone. Learn how Resilience can support your biologic: https://hubs.ly/Q02H-MX60 #biologics #biologicsdevelopment #biologicsmanufacturing
To view or add a comment, sign in
-
Highlights from our VP, Head of Manufacturing Operations, Ravishankar Kasturi's insightful session at the Biopharma Conclave 2024 on "Continuous Bioprocessing - Revamping Biologic Manufacturing". In this session, Ravi highlighted how Enzene's revolutionary platform, EnzeneX™, is transforming biologics manufacturing by enhancing productivity, reducing costs, and making life-saving medicines more accessible globally. Key points highlighted during the session: ➤ The way EnzeneX™ operates continuously from upstream to downstream, enhancing productivity with a smaller facility footprint. ➤ How EnzeneX™ achieves higher cell densities and viabilities, resulting in up to ten times greater productivity than traditional methods. CPhI Conferences #Biologics #ContinuousManufacturing #EnzeneX
We concluded the Day 1 of 6th Edition of the Biopharma Conclave (Biosimilars & Biologics) with Ravishankar Kasturi, Head of Operations, Enzene Biosciences Ltd discussing his insights on “Continuous Bioprocessing-Revamping Biologic Manufacturing” Ruchi Kedia Rima Fodkar Archana Shantharam Sheron David Pratibha Gupta Sarfaraz Ali #BiopharmaConclave #Biosimilars #Biologics #CPHIConferences #InformaMarkets #CellAndGeneTherapy
To view or add a comment, sign in
-
Lonza announced the completion of the first GMP product batch supported from the recently completed next-generation mammalian manufacturing facility in Portsmouth (US). "The first GMP batch release marks a significant milestone, allowing the facility to help meet the increasing market demand for small- to mid-scale volumes of mammalian-derived biologics and support the implementation of high-titer and high-throughput platform processes." Stefan Egli Read more >> https://lnkd.in/eHWjpTEi #Biologics #Biomanufacturing
To view or add a comment, sign in
930 followers